Distinct roles of Smads and microRNAs in TGF-β signaling during kidney diseases

Hong Kong Journal of Nephrology

Volumn 15, Issue 1, 2013, Pages 14-21

  Li, Rong ^a,b   Lan, Hui Y ^a   Chung, Arthur C K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b First People's Hospital of Yunnan Province   (China)

Author keywords

chronic kidney disease; microRNAs; Smads; transforming growth factor signaling

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GW 788388; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IN 1130; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN INHIBITOR; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DNA SEQUENCE; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE; HOMEOSTASIS; HUMAN; KIDNEY FIBROSIS; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84878273492     PISSN: 15615413     EISSN: 18764371     Source Type: Journal    
DOI: 10.1016/j.hkjn.2013.03.003     Document Type: Review

References (71)

1. A.B. Roberts Molecular and cell biology of TGF-beta Miner Electrolyte Metab 24 1998 111 119
2. A. Moustakas, and C.H. Heldin The regulation of TGFbeta signal transduction Development 136 2009 3699 3714
3. M.Y. Wu, and C.S. Hill TGF-β superfamily signaling in embryonic development and homeostasis Dev Cell 16 2009 329 343
4. P. Kavsak, R.K. Rasmussen, C.G. Causing, S. Bonni, H. Zhu, and G.H. Thomsen Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation Mol Cell 6 2000 1365 1375
5. T. Ebisawa, M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, and T. Imamura Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation J Biol Chem 276 2001 12477 12480
6. E.P. Böttinger TGF-beta in renal injury and disease Semin Nephrol 27 2007 309 320
7. W. Wang, V. Koka, and H.Y. Lan Transforming growth factor-beta and Smad signalling in kidney diseases Nephrology 10 2005 48 56
8. H.Y. Lan, and A.C.K. Chung TGF-β/Smad signaling in kidney disease Semin Nephrol 32 2012 236 243
9. X.M. Meng, A.C.K. Chung, and H.Y. Lan Role of the TGF-β/BMP-7/Smad pathways in renal diseases Clin Sci 124 2013 243 254
10. H.Y. Lan Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation Int J Biol Sci 7 2011 1056 1067
11. C. Medina, M.J. Santos-Martinez, A. Santana, M.C. Paz-Cabrera, M.J. Johnston, and M. Mourelle Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis J Pathol 224 2011 461 472
12. X.M. Meng, X.R. Huang, J. Xiao, H.Y. Chen, X. Zhong, and A.C.K. Chung Diverse roles of TGF-beta receptor II in renal fibrosis and inflammation in vivo and in vitro J Pathol 227 2012 175 188
13. X.R. Huang, A.C.K. Chung, X.J. Wang, K.N. Lai, and H.Y. Lan Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease Am J Physiol Renal Physiol 295 2008 F118 F127
14. M. Sato, Y. Muragaki, S. Saika, A.B. Roberts, and A. Ooshima Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction J Clin Invest 112 2003 1486 1494
15. H.Y. Lan, W. Mu, N. Tomita, X.R. Huang, J.H. Li, and H.-J. Zhu Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model J Am Soc Nephrol 14 2003 1535 1548
16. Y. Terada, S. Hanada, A. Nakao, M. Kuwahara, S. Sasaki, and F. Marumo Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney Kidney Int 61 2002 S94 S98
17. A.C.K. Chung, X.R. Huang, L. Zhou, R. Heuchel, K.N. Lai, and H.Y. Lan Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice Nephrol Dial Transplant 24 2009 1443 1454
18. F. Yang, X.R. Huang, A.C.K. Chung, C.-C. Hou, K.N. Lai, and H.Y. Lan Essential role for Smad3 in angiotensin II-induced tubular epithelial mesenchymal transition J Pathol 221 2010 390 401
19. C.C. Hou, W. Wang, X.R. Huang, P. Fu, T.H. Chen, and D. Sheikh-Hamad Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney Am J Pathology 166 2005 761 771
20. W. Wang, X.R. Huang, E. Canlas, K. Oka, L.D. Truong, and C. Deng Essential role of Smad3 in angiotensin II-induced vascular fibrosis Circ Res 98 2006 1032 1039
21. J.H. Li, X.R. Huang, H.J. Zhu, M. Oldfield, M. Cooper, and L.D. Truong Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease FASEB J 18 2004 176 178
22. A.C.K. Chung, H. Zhang, Y.-Z. Kong, J.-J. Tan, X.R. Huang, and J.B. Kopp Advanced glycation end-products induce tubular CTGF via TGF-β-independent Smad3 signaling J Am Soc Nephrol 21 2010 249 260
23. M. Fujimoto, Y. Maezawa, K. Yokote, K. Joh, K. Kobayashi, and H. Kawamura Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy Biochem Biophys Res Commun 305 2003 1002 1007
24. M. Isono, S. Chen, S. Won Hong, M. Carmen Iglesias-de la Cruz, and F.N. Ziyadeh Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells Biochem Biophys Res Commun 296 2002 1356 1365
25. H.Y. Chen, X.R. Huang, W. Wang, J.H. Li, R.L. Heuchel, and A.C.K. Chung The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential Diabetes 60 2011 590 601
26. L. Zhou, P. Fu, X.R. Huang, F. Liu, A.C.K. Chung, and K.N. Lai Mechanism of chronic aristolochic acid nephropathy: role of Smad3 Am J Physiol Renal Physiol 298 2010 F1006 F1017
27. E. Piek, W.J. Ju, J. Heyer, D. Escalante-Alcalde, C.L. Stewart, and M. Weinstein Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts J Biol Chem.2001 276 1994 5 53
28. S. Dennler, S. Huet, and J.M. Gauthier A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 Oncogene 18 1999 1643 1648
29. F. Verrecchia, M.L. Chu, and A. Mauviel Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach J Biol Chem 276 2001 17058 17062
30. W. Ju, A. Ogawa, J. Heyer, D. Nierhof, L. Yu, and R. Kucherlapati Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation Mol Cell Biol 26 2006 654 667
31. X.M. Meng, X.R. Huang, A.C.K. Chung, W. Qin, X. Shao, and P. Igarashi Smad2 protects against TGF-β/Smad3-mediated renal fibrosis J Am Soc Nephrol 21 2010 1477 1487
32. X. Yang, C. Li, P.L. Herrera, and C.X. Deng Generation of Smad4/Dpc4 conditional knockout mice Genesis 32 2002 80 81
33. X.M. Meng, X.R. Huang, J. Xiao, A.C.K. Chung, W. Qin, and H.Y. Chen Disruption of Smad4 impairs TGF-Β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro Kidney Int 81 2012 266 279
34. G. von Gersdorff, K. Susztak, F. Rezvani, M. Bitzer, D. Liang, and E.P. Böttinger Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β J Biol Chem 275 2000 11320 11326
35. R.P. Nagarajan, J. Zhang, W. Li, and Y. Chen Regulation of Smad7 promoter by direct association with Smad3 and Smad4 J Biol Chem 274 1999 33412 33418
36. N.G. Denissova, C. Pouponnot, J. Long, D. He, and F. Liu Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoter Proc Natl Acad Sci U S A 97 2000 6397 6402
37. A. Nakao, M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, and R. Heuchel Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling Nature 389 1997 631 635
38. H.Y. Lan Smad7 as a therapeutic agent for chronic kidney diseases Front Biosci 13 2008 4984 4992
39. F.Y. Liu, X.Z. Li, Y.M. Peng, H. Liu, and Y.H. Liu Arkadia regulates TGF-beta signaling during renal tubular epithelial to mesenchymal cell transition Kidney Int 73 2008 588 594
40. H. Fukasawa, T. Yamamoto, A. Togawa, N. Ohashi, Y. Fujigaki, and T. Oda Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice Proc Natl Acad Sci U S A 101 2004 8687 8692
41. Y. Inoue, and T. Imamura Regulation of TGF-beta family signaling by E3 ubiquitin ligases Cancer Sci 99 2008 2107 2112
42. J. Yang, X. Zhang, Y. Li, and Y. Liu Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-β1 signaling J Am Soc Nephrol 14 2003 3167 3177
43. R. Tan, W. He, X. Lin, L.P. Kiss, and Y. Liu Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication Am J Physiol Renal Physiol 294 2008 F1076 F1083
44. F. Yang, A.C.K. Chung, X.R. Huang, and H.Y. Lan Angiotensin II induces connective tissue growth factor and collagen I Expression via transforming growth factor-β-dependent and -independent Smad pathways: the role of Smad3 Hypertension 54 2009 877 884
45. P. Kantharidis, B. Wang, R.M. Carew, and H.Y. Lan Diabetes complications: the microRNA perspective Diabetes 60 2011 1832 1837
46. A.C. Chung, Y. Dong, W. Yang, X. Zhong, R. Li, and H.Y. Lan Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3-regulated microRNAs Mol Ther 21 2013 388 398
47. M. Kato, L. Wang, S. Putta, M. Wang, H. Yuan, and G. Sun Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-β-induced collagen expression in kidney cells J Biol Chem 285 2010 34004 34015
48. X. Zhong, A.C.K. Chung, H.Y. Chen, X.M. Meng, and H.Y. Lan Smad3-mediated upregulation of miR-21 promotes renal fibrosis J Am Soc Nephrol 22 2011 1668 1681
49. A.C.K. Chung, X.R. Huang, X. Meng, and H.Y. Lan miR-192 mediates TGF-β/Smad3-driven renal fibrosis J Am Soc Nephrol 21 2010 1317 1325
50. X. Zhong, A.C.K. Chung, H.Y. Chen, Y. Dong, X.M. Meng, and R. Li miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes Diabetologia 56 2013 663 674
51. M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, and J.J. Rossi MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors Proc Natl Acad Sci U S A 104 2007 3432 3437
52. Q. Wang, Y. Wang, A.W. Minto, J. Wang, Q. Shi, and X. Li MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy FASEB J 22 2008 4126 4135
53. Q. Zhou, J. Fan, X. Ding, W. Peng, X. Yu, and Y. Chen TGF-β-induced MiR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells J Biol Chem 285 2010 40019 40027
54. A.J. Kriegel, Y. Fang, Y. Liu, Z. Tian, D. Mladinov, and I.R. Matus MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor β1: a novel role of miR-382 Nucleic Acids Res 38 2010 8338 8347
55. B. Du, L.M. Ma, M.B. Huang, H. Zhou, H.L. Huang, and P. Shao High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells FEBS Lett 584 2010 811 816
56. W. Qin, A.C.K. Chung, X.R. Huang, X.M. Meng, D.S.C. Hui, and C.M. Yu TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29 J Am Soc Nephrol 22 2011 1462 1474
57. B. Wang, P. Koh, C. Winbanks, M.T. Coughlan, A. McClelland, and A. Watson miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression Diabetes 60 2011 280 287
58. B.N. Davis, A.C. Hilyard, G. Lagna, and A. Hata SMAD proteins control DROSHA-mediated microRNA maturation Nature 454 2008 56 61
59. G. Liu, A. Friggeri, Y. Yang, J. Milosevic, Q. Ding, and V.J. Thannickal miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis J Exp Med 207 2010 1589 1597
60. L. Yaswen, A.B. Kulkarni, T. Fredrickson, B. Mittleman, R. Schiffman, and S. Payne Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse Blood 87 1996 1439 1445
61. M.O. Li, S. Sanjabi, and R.A. Flavell Transforming growth factor-β Controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms Immunity 25 2006 455 471
62. M.O. Li, Y.Y. Wan, and R.A. Flavell T Cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation Immunity 26 2007 579 591
63. W. Wang, X.R. Huang, A.G. Li, F. Liu, J.-H. Li, and L.D. Truong Signaling mechanism of TGF-β1 in prevention of renal inflammation: role of Smad7 J Am Soc Nephrol 16 2005 1371 1383
64. X.R. Huang, A.C.K. Chung, L. Zhou, X.J. Wang, and H.Y. Lan Latent TGF-β1 protects against crescentic glomerulonephritis J Am Soc Nephrol 19 2008 233 242
65. Y. Kanamaru, A. Nakao, M. Mamura, Y. Suzuki, I. Shirato, and K. Okumura Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis J Immunol 166 2001 2818 2823
66. C. Hill, A. Flyvbjerg, R. Rasch, M. Bak, and A. Logan Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney J Endocrinol 170 2001 647 651
67. L.M. Russo, E. del Re, D. Brown, and H.Y. Lin Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy:amelioration by soluble TGF-β type II receptor Diabetes 56 2007 380 388
68. M. Petersen, M. Thorikay, M. Deckers, M. van Dinther, E.T. Grygielko, and F. Gellibert Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis Kidney Int 73 2008 705 715
69. J.A. Moon, H.T. Kim, I.S. Cho, Y.Y. Sheen, and D.K. Kim IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy Kidney Int 70 2006 1234 1243
70. J. Li, X. Qu, J. Yao, G. Caruana, S.D. Ricardo, and Y. Yamamoto Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy Diabetes 59 2010 2612 2624
71. L.X. Tang, R.H. He, G. Yang, J.J. Tan, L. Zhou, and X.M. Meng Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro PLoS One 7 2012 e31350